Picture of Dynavax Technologies logo

DVAX — Dynavax Technologies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Dynavax Technologies Corp reports results for the quarter ended in September - Earnings Summary

* Dynavax Technologies Corp  DVAX.OQ  reported quarterly
adjusted
earnings of 10 cents​​ per share for the quarter ended in
September, lower than the same quarter last year, when the
company reported EPS of 43 cents.  The mean expectation of
four analysts for the quarter was for a loss of one cent per
share. Wall Street expected results to range from -7 cents to 4
cents per share.
    * Revenue fell 58.6% to $69.51 million from a year ago;
analysts
expected $60.30 million. 
    * Dynavax Technologies Corp's reported EPS for the quarter
was 10
cents​.
    * The company reported quarterly net income of $14.29
million.
    * Dynavax Technologies Corp shares had fallen by 4.5% this
quarter and gained 32.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 82% in
the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Dynavax
Technologies Corp is $25.00 

This summary was machine generated from LSEG data November 2 at
09:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.01          0.10           Beat
 Jun. 30 2023      -0.09          0.03           Beat
 Mar. 31 2023      -0.13          -0.19          Missed
 Dec. 31 2022      0.43           0.45           Beat

Recent news on Dynavax Technologies

See all news